Allergan plc (NYSE: AGN) announced that its merger agreement with Pfizer (NYSE: PFE) has been terminated by mutual agreement, effective ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Hot Corp. News Management Comments Mergers and Acquisitions

Morgan Stanley Resumes Pfizer (PFE) at EqualweightApril 7, 2016 8:27 AM Jefferies Reiterates Buy on Pfizer (PFE) Post Allergen Collapse, PT Trimmed to $39April 7, 2016 8:23 AM JPMorgan Resumes Allergen (AGN) at OverweightApril 7, 2016 7:46 AM Allergan (AGN) Ratings Affirmed by Moody's Amid Scrubbed Deal with PfizerApril 6, 2016 4:51 PM Allergen's (AGN) Price Target Reduced to $282 at Deutsche BankApril 6, 2016 3:40 PM Pfizer (PFE) Pushes Higher after Ending Allergan Deal; Shares Cross Above 200 DMAApril 6, 2016 12:35 PM Piper Jaffray Sees Value in Allergen (AGN) Post-Pfizer; PT to $311April 6, 2016 11:29 AM BMO Capital Reiterates Outperform on Pfizer (PFE) Following Allergan Merger TerminationApril 6, 2016 10:42 AM Standalone Allergan (AGN) Could Be Worth $300 - RBC April 6, 2016 8:36 AM Leerink Partners Cuts Price Target on Allergan (AGN) Following New U.S. Treasury Regulations April 6, 2016 7:13 AM Pfizer (PFE) Announces Termination of Merger Agreement with Allergan (AGN)April 6, 2016 6:45 AM Allergan Reiterates Strong Standalone Growth Profile and Strategy Following Termination of Pfizer TransactionApril 6, 2016 6:45 AM Pfizer Announces Termination of Proposed Combination with AllerganApril 6, 2016 6:45 AM Mizuho Securities Downgrades Allergen (AGN) to NeutralApril 6, 2016 6:25 AM Deja vu for Paulson as Allergan loss hurts U.S. hedge fundsApril 5, 2016 9:13 PM